Literature DB >> 33450094

Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex-specific manner.

Shazia F Bhat1, Sara E Pinney2, Katherine M Kennedy3, Cole R McCourt4, Miles A Mundy5, Michael G Surette3,6,7, Deborah M Sloboda3, Rebecca A Simmons6,8.   

Abstract

KEY POINTS: The prevalence of obesity and non-alcoholic fatty liver disease in children is dramatically increasing at the same time as consumption of foods with a high sugar content. Intake of high fructose corn syrup (HFCS) is a possible aetiology as it is thought to be more lipogenic than glucose. In a mouse model, HFCS intake during adolescence increased fat mass and hepatic lipid levels in male and female mice. However, only males showed impaired glucose tolerance. Multiple metabolites including lipids, bile acids, carbohydrates and amino acids were altered in liver in a sex-specific manner at 6 weeks of age. Some of these changes were also present in adulthood even though HFCS exposure ended at 6 weeks. HFCS significantly altered the gut microbiome, which was associated with changes in key microbial metabolites. These results suggest that HFCS intake during adolescence has profound metabolic changes that are linked to changes in the microbiome and these changes are sex-specific. ABSTRACT: The rapid increase in obesity, diabetes and fatty liver disease in children over the past 20 years has been linked to increased consumption of high fructose corn syrup (HFCS), making it essential to determine the short- and long-term effects of HFCS during this vulnerable developmental window. We hypothesized that HFCS exposure during adolescence significantly impairs hepatic metabolic signalling pathways and alters gut microbial composition, contributing to changes in energy metabolism with sex-specific effects. C57bl/6J mice with free access to HFCS during adolescence (3-6 weeks of age) underwent glucose tolerance and body composition testing and hepatic metabolomics, gene expression and triglyceride content analysis at 6 and 30 weeks of age (n = 6-8 per sex). At 6 weeks HFCS-exposed mice had significant increases in fat mass, glucose intolerance, hepatic triglycerides (females) and de novo lipogenesis gene expression (ACC, DGAT, FAS, ChREBP, SCD, SREBP, CPT and PPARα) with sex-specific effects. At 30 weeks, HFCS-exposed mice also had abnormalities in glucose tolerance (males) and fat mass (females). HFCS exposure enriched carbohydrate, amino acid, long chain fatty acid and secondary bile acid metabolism at 6 weeks with changes in secondary bile metabolism at 6 and 30 weeks. Microbiome studies performed immediately before and after HFCS exposure identified profound shifts of microbial species in male mice only. In summary, short-term HFCS exposure during adolescence induces fatty liver, alters important metabolic pathways, some of which continue to be altered in adulthood, and changes the microbiome in a sex-specific manner.
© 2021 The Authors. The Journal of Physiology © 2021 The Physiological Society.

Entities:  

Keywords:  adolescence; high fructose corn syrup; metabolomics; microbiome

Mesh:

Substances:

Year:  2021        PMID: 33450094      PMCID: PMC8274821          DOI: 10.1113/JP280034

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  91 in total

Review 1.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

2.  Generation of multimillion-sequence 16S rRNA gene libraries from complex microbial communities by assembling paired-end illumina reads.

Authors:  Andrea K Bartram; Michael D J Lynch; Jennifer C Stearns; Gabriel Moreno-Hagelsieb; Josh D Neufeld
Journal:  Appl Environ Microbiol       Date:  2011-04-01       Impact factor: 4.792

3.  Sugar-sweetened Beverage Consumption Among U.S. Youth, 2011-2014.

Authors:  Asher Rosinger; Kirsten Herrick; Jaime Gahche; Sohyun Park
Journal:  NCHS Data Brief       Date:  2017-01

4.  Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation.

Authors:  Erik Kwidzinski; Jörg Bunse; Orhan Aktas; Daniel Richter; Leman Mutlu; Frauke Zipp; Robert Nitsch; Ingo Bechmann
Journal:  FASEB J       Date:  2005-06-06       Impact factor: 5.191

Review 5.  Fructose induced lipogenesis: from sugar to fat to insulin resistance.

Authors:  Varman T Samuel
Journal:  Trends Endocrinol Metab       Date:  2010-11-09       Impact factor: 12.015

Review 6.  The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature.

Authors:  Susan Harrington
Journal:  J Sch Nurs       Date:  2008-02       Impact factor: 2.835

7.  The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids.

Authors:  Cholsoon Jang; Sheng Hui; Wenyun Lu; Alexis J Cowan; Raphael J Morscher; Gina Lee; Wei Liu; Gregory J Tesz; Morris J Birnbaum; Joshua D Rabinowitz
Journal:  Cell Metab       Date:  2018-02-06       Impact factor: 27.287

8.  Fructose:glucose ratios--a study of sugar self-administration and associated neural and physiological responses in the rat.

Authors:  AnneMarie Levy; Paul Marshall; Yan Zhou; Mary Jeanne Kreek; Katrina Kent; Stephen Daniels; Ari Shore; Tiana Downs; Maria Fernanda Fernandes; David M Mutch; Francesco Leri
Journal:  Nutrients       Date:  2015-05-22       Impact factor: 5.717

9.  Microbial dysbiosis associated with impaired intestinal Na+/H+ exchange accelerates and exacerbates colitis in ex-germ free mice.

Authors:  Christy A Harrison; Daniel Laubitz; Christina L Ohland; Monica T Midura-Kiela; Karuna Patil; David G Besselsen; Deepa R Jamwal; Christian Jobin; Fayez K Ghishan; Pawel R Kiela
Journal:  Mucosal Immunol       Date:  2018-06-06       Impact factor: 7.313

10.  Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Authors:  Clara Depommier; Amandine Everard; Céline Druart; Hubert Plovier; Matthias Van Hul; Sara Vieira-Silva; Gwen Falony; Jeroen Raes; Dominique Maiter; Nathalie M Delzenne; Marie de Barsy; Audrey Loumaye; Michel P Hermans; Jean-Paul Thissen; Willem M de Vos; Patrice D Cani
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

View more
  6 in total

1.  Melatonin Alleviates PM2.5-Induced Hepatic Steatosis and Metabolic-Associated Fatty Liver Disease in ApoE-/- Mice.

Authors:  Zhou Du; Shuang Liang; Yang Li; Jingyi Zhang; Yang Yu; Qing Xu; Zhiwei Sun; Junchao Duan
Journal:  Oxid Med Cell Longev       Date:  2022-06-08       Impact factor: 7.310

2.  Prolonged Changes in Hepatic Mitochondrial Activity and Insulin Sensitivity by High Fructose Intake in Adolescent Rats.

Authors:  Arianna Mazzoli; Cristina Gatto; Raffaella Crescenzo; Luisa Cigliano; Susanna Iossa
Journal:  Nutrients       Date:  2021-04-19       Impact factor: 5.717

3.  Effects of high fructose corn syrup on intestinal microbiota structure and obesity in mice.

Authors:  Xiaorong Wang; Liying Zhu; Xiaoqiong Li; Xin Wang; Ruirong Hao; Jinjun Li
Journal:  NPJ Sci Food       Date:  2022-03-02

4.  Liver Transcriptome and Gut Microbiome Analysis Reveals the Effects of High Fructose Corn Syrup in Mice.

Authors:  Yu Shen; Yangying Sun; Xiaoli Wang; Yingping Xiao; Lingyan Ma; Wentao Lyu; Zibin Zheng; Wen Wang; Jinjun Li
Journal:  Front Nutr       Date:  2022-06-30

Review 5.  Roles of gut microbiota and metabolites in overweight and obesity of children.

Authors:  Shengan Zhang; Yanqi Dang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

6.  Excessive Intake of High-Fructose Corn Syrup Drinks Induces Impaired Glucose Tolerance.

Authors:  Hidemi Hattori; Yuma Hanai; Yuto Oshima; Hiroaki Kataoka; Nozomu Eto
Journal:  Biomedicines       Date:  2021-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.